98 related articles for article (PubMed ID: 8529780)
1. Open randomized study comparing doxycycline and co-amoxiclav in the treatment of acute suppurative tracheobronchitis in adults. The Collaborative Group of the Centre Universitaire de Medécine Générale de L'Université Libre de Bruxelles (CUMG-ULB) Investigators.
Sternon J
J Int Med Res; 1995; 23(5):369-76. PubMed ID: 8529780
[TBL] [Abstract][Full Text] [Related]
2. Comparison of azithromycin and co-amoxiclav in the treatment of acute tracheobronchitis and acute infectious exacerbations of chronic bronchitis in adults. Azithromycin Study Group.
Biebuyck XA
J Int Med Res; 1996; 24(5):407-18. PubMed ID: 8895044
[TBL] [Abstract][Full Text] [Related]
3. Once-daily, 3-day azithromycin versus a three-times-daily, 10-day course of co-amoxiclav in the treatment of adults with lower respiratory tract infections: results of a randomized, double-blind comparative study.
Gris P
J Antimicrob Chemother; 1996 Jun; 37 Suppl C():93-101. PubMed ID: 8818850
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of the clinical and microbiological efficacy of co-amoxiclav vs cefixime or ciprofloxacin in bacterial exacerbation of chronic bronchitis.
Cazzola M; Vinciguerra A; Beghi GF; Paizis G; Giura R; Madonini V; Fiorentini F; Consigli GF; Tonna M; Casalini A
J Chemother; 1995 Oct; 7(5):432-41. PubMed ID: 8596127
[TBL] [Abstract][Full Text] [Related]
5. Dirithromycin versus amoxiclav in the treatment of acute exacerbations of chronic bronchitis.
Van Royen P; Betz W; Heyrman J; Taziaux P; Van den Haute M; Poelman M
J Int Med Res; 1997; 25(1):33-40. PubMed ID: 9027671
[TBL] [Abstract][Full Text] [Related]
6. A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome.
Hoepelman IM; Möllers MJ; van Schie MH; Greefhorst AP; Schlösser NJ; Sinninghe Damsté EJ; van de Moosdijk CN; Dalinghaus WH; Eland ME; Mol SJ; Rozenberg-Arska M
Int J Antimicrob Agents; 1997 Jan; 9(3):141-6. PubMed ID: 9552709
[TBL] [Abstract][Full Text] [Related]
7. Short-term sequential administration of amoxicillin/clavulanate potassium and doxycycline in the treatment of recurrent/progressive periodontitis.
Matisko MW; Bissada NF
J Periodontol; 1993 Jun; 64(6):553-8. PubMed ID: 8393108
[TBL] [Abstract][Full Text] [Related]
8. Ofloxacin in the treatment of lower respiratory tract infections: report of a prospective, comparative trial.
Khajotia RR; Vetter N; Harazin H
Clin Ther; 1991; 13(4):460-6. PubMed ID: 1933997
[TBL] [Abstract][Full Text] [Related]
9. A randomized, comparative study to evaluate the efficacy and tolerability of a 3-day course of azithromycin versus a 10-day course of co-amoxiclav as treatment of adult patients with lower respiratory tract infections.
Zachariah J
J Antimicrob Chemother; 1996 Jun; 37 Suppl C():103-13. PubMed ID: 8818851
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of azithromycin and amoxicillin/clavulanic acid in the treatment of lower respiratory tract infections.
Balmes P; Clerc G; Dupont B; Labram C; Pariente R; Poirier R
Eur J Clin Microbiol Infect Dis; 1991 May; 10(5):437-9. PubMed ID: 1651860
[TBL] [Abstract][Full Text] [Related]
11. A multinational, multicentre, non-blinded, randomized study of moxifloxacin oral tablets compared with co-amoxiclav oral tablets in the treatment of acute exacerbation of chronic bronchitis.
Schaberg T; Ballin I; Huchon G; Bassaris H; Hampel B; Reimnitz P;
J Int Med Res; 2001; 29(4):314-28. PubMed ID: 11675905
[TBL] [Abstract][Full Text] [Related]
12. Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis.
Starakis I; Gogos CA; Bassaris H
Int J Antimicrob Agents; 2004 Feb; 23(2):129-37. PubMed ID: 15013037
[TBL] [Abstract][Full Text] [Related]
13. High-dosage co-amoxiclav in a single dose versus 7 days of co-trimoxazole as treatment of uncomplicated lower urinary tract infection in women.
Masterton RG; Bochsler JA
J Antimicrob Chemother; 1995 Jan; 35(1):129-37. PubMed ID: 7768760
[TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of once-daily ceftibuten compared with co-amoxiclav in the treatment of acute bacterial sinusitis.
De Abate CA; Perrotta RJ; Dennington ML; Ziering RM
J Chemother; 1992 Dec; 4(6):358-63. PubMed ID: 1287138
[TBL] [Abstract][Full Text] [Related]
15. Loracarbef (LY 163892) vs amoxicillin/clavulanate in bacterial maxillary sinusitis.
Sydnor TA; Scheld WM; Gwaltney J; Nielsen RW; Huck W; Therasse DG
Ear Nose Throat J; 1992 May; 71(5):225-32. PubMed ID: 1505371
[TBL] [Abstract][Full Text] [Related]
16. A prospective comparison of co-amoxiclav and the combination of chloramphenicol, doxycycline, and co-trimoxazole for the oral maintenance treatment of melioidosis.
Rajchanuvong A; Chaowagul W; Suputtamongkol Y; Smith MD; Dance DA; White NJ
Trans R Soc Trop Med Hyg; 1995; 89(5):546-9. PubMed ID: 8560537
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of a new ciprofloxacin suspension compared with co-amoxiclav tablets in the treatment of acute exacerbations of chronic bronchitis.
Read RC; Kuss A; Berrisoul F; Kearsley N; Torres A; Kubin R
Respir Med; 1999 Apr; 93(4):252-61. PubMed ID: 10464889
[TBL] [Abstract][Full Text] [Related]
18. [The role of anti-inflammatory agents in the treatment of acute salpingitis. A randomized study of 40 patients with celioscopic control].
Bassil S; Le Bouedec G; Mage G; Pouly JL; Canis M; Wattiez A; Chapron C; Bruhat MA
J Gynecol Obstet Biol Reprod (Paris); 1991; 20(8):1063-7. PubMed ID: 1839799
[TBL] [Abstract][Full Text] [Related]
19. Twice-daily antibiotics in the treatment of acute otitis media: trimethoprim-sulfamethoxazole versus amoxicillin-clavulanate.
Feldman W; Sutcliffe T; Dulberg C
CMAJ; 1990 Jan; 142(2):115-8. PubMed ID: 2403833
[TBL] [Abstract][Full Text] [Related]
20. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis.
Zeckel ML; Jacobson KD; Guerra FJ; Therasse DG; Farlow D
Clin Ther; 1992; 14(2):214-29. PubMed ID: 1611645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
